CTNM CIK: 1855175

Contineum Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY23:
19.3
FY24:
−32.8
FY25:
−55.3
Change from FY23 to FY25
millions USD
FY23:
−65.6
FY24:
−69.7
FY25:
−3.71
Change from FY23 to FY25
millions USD
FY23:
56.2
FY24:
109
FY25:
113
millions USD
FY23:
9.96
FY24:
6.42
FY25:
53.7
(positive)
Change from FY23 to FY25
millions USD
FY23:
18.9
FY24:
−33.4
FY25:
−55.5

All amounts in millions USD Data source:SEC EDGAR